Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

ALEC Alector Inc

Price (delayed)

$1.31

Market cap

$130.99M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.25

Enterprise value

$132.22M

Alector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. The Company is developing a broad portfolio of innate immune system ...

Highlights
ALEC's EPS is up by 9% YoY
The debt has grown by 9% YoY but it has contracted by 3.5% from the previous quarter
The equity has decreased by 47% YoY and by 25% QoQ
ALEC's gross profit is down by 12% from the previous quarter and by 8% YoY

Key stats

What are the main financial stats of ALEC
Market
Shares outstanding
99.99M
Market cap
$130.99M
Enterprise value
$132.22M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.37
Price to sales (P/S)
1.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.5
Earnings
Revenue
$88.34M
Gross profit
$88.34M
Operating income
-$145.98M
Net income
-$123.44M
EBIT
-$123.32M
EBITDA
-$114.92M
Free cash flow
-$230.08M
Per share
EPS
-$1.25
EPS diluted
-$1.25
Free cash flow per share
-$2.31
Book value per share
$0.95
Revenue per share
$0.89
TBVPS
$4.11
Balance sheet
Total assets
$408.3M
Total liabilities
$313.69M
Debt
$41.05M
Equity
$94.61M
Working capital
$256.88M
Liquidity
Debt to equity
0.43
Current ratio
3.34
Quick ratio
3.25
Net debt/EBITDA
-0.01
Margins
EBITDA margin
-130.1%
Gross margin
100%
Net margin
-139.7%
Operating margin
-165.3%
Efficiency
Return on assets
-25.1%
Return on equity
-100.6%
Return on invested capital
-34.5%
Return on capital employed
-41.3%
Return on sales
-139.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALEC stock price

How has the Alector stock price performed over time
Intraday
4.8%
1 week
18.55%
1 month
18.02%
1 year
-75.92%
YTD
-30.69%
QTD
6.5%

Financial performance

How have Alector's revenue and profit performed over time
Revenue
$88.34M
Gross profit
$88.34M
Operating income
-$145.98M
Net income
-$123.44M
Gross margin
100%
Net margin
-139.7%
ALEC financials
The net margin has contracted by 18% from the previous quarter and by 12% YoY
ALEC's operating margin is down by 15% since the previous quarter and by 10% year-on-year
ALEC's gross profit is down by 12% from the previous quarter and by 8% YoY
The revenue has declined by 12% since the previous quarter and by 8% year-on-year

Price vs fundamentals

How does ALEC's price correlate with its fundamentals
Price vs fundamentals
Earnings waterfall
Price vs fair value

Growth

What is Alector's growth rate over time
ALEC growth chart

Valuation

What is Alector stock price valuation
P/E
N/A
P/B
1.37
P/S
1.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.5
Valuation vs average
Price to earnings (P/E)
ALEC's EPS is up by 9% YoY
Price to book (P/B)
ALEC's P/B is 66% below its 5-year quarterly average of 4.0 and 43% below its last 4 quarters average of 2.4
The equity has decreased by 47% YoY and by 25% QoQ
Price to sales (P/S)
The stock's price to sales (P/S) is 93% less than its 5-year quarterly average of 22.1 and 68% less than its last 4 quarters average of 4.6
The revenue has declined by 12% since the previous quarter and by 8% year-on-year

Efficiency

How efficient is Alector business performance
The return on equity has declined by 40% year-on-year and by 21% since the previous quarter
Alector's ROA has decreased by 37% YoY and by 16% from the previous quarter
The return on invested capital has declined by 32% year-on-year and by 13% since the previous quarter
ALEC's ROS is down by 18% from the previous quarter and by 16% YoY

Dividends

What is ALEC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALEC.

Financial health

How did Alector financials performed over time
Assets vs liabilities
ALEC's total assets is 30% greater than its total liabilities
ALEC's total assets is down by 36% year-on-year and by 13% since the previous quarter
ALEC's total liabilities is down by 31% year-on-year and by 8% since the previous quarter
Debt vs equity
The debt is 57% less than the equity
The debt to equity has soared by 105% year-on-year and by 26% since the previous quarter
The equity has decreased by 47% YoY and by 25% QoQ
Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.